SI Institute of the pediatrics, obstetrics and gynecology
About SI Institute of the pediatrics, obstetrics and gynecology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at SI Institute of the pediatrics, obstetrics and gynecology
During the past decade, SI Institute of the pediatrics, obstetrics and gynecology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
2012-07-11
2021-10-18
Completed
165
A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase
2014-06-16
2020-01-29
Completed
62
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SI Institute of the pediatrics, obstetrics and gynecology
According to Clinical.Site data, the most researched conditions in "SI Institute of the pediatrics, obstetrics and gynecology" are
"Hepatitis B, Chronic" (1 trials) and "Pediatric Immuno-Tolerant Chronic Hepatitis B" (1 trials). Many other conditions were trialed in "SI Institute of the pediatrics, obstetrics and gynecology" in a lesser frequency.
Clinical Trials Intervention Types at SI Institute of the pediatrics, obstetrics and gynecology
Most popular intervention types in "SI Institute of the pediatrics, obstetrics and gynecology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Entecavir" (1 trials), "Lamivudine" (1 trials), "Pegylated Interferon Alfa-2A" (1 trials) and "peginterferon alfa-2a [Pegasys]" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SI Institute of the pediatrics, obstetrics and gynecology
The vast majority of trials in "SI Institute of the pediatrics, obstetrics and gynecology" are
2 trials for "All" genders.
Clinical Trials Status at SI Institute of the pediatrics, obstetrics and gynecology
Currently, there are NaN active trials in "SI Institute of the pediatrics, obstetrics and gynecology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in SI Institute of the pediatrics, obstetrics and gynecology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SI Institute of the pediatrics, obstetrics and gynecology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".